The business of RNAi therapeutics

被引:57
|
作者
Haussecker, Dirk [1 ]
机构
[1] Stanford Sch Med, Dept Pediat, Stanford, CA 94305 USA
关键词
D O I
10.1089/hum.2008.007
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
[No abstract available]
引用
收藏
页码:451 / 462
页数:12
相关论文
共 50 条
  • [1] The Business of RNAi Therapeutics in 2012
    Haussecker, Dirk
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2012, 1
  • [2] RNAi therapeutics
    Limmer, S
    JOURNAL OF BIOTECHNOLOGY, 2005, 118 : S69 - S69
  • [3] The world of RNAi therapeutics
    Manoharan, M.
    FEBS OPEN BIO, 2019, 9 : 50 - 50
  • [4] RNAi therapeutics delivered
    Manoharan, Muthiah
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [5] Biomimetic chemistry of RNAi therapeutics
    Manoharan, Muthiah
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [6] RNAi Therapeutics Gaining Ground
    Liszewski, Kathy
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2010, 30 (07): : 22 - 23
  • [7] RNAi Therapeutics: State of the State
    Maraganore, John
    NUCLEIC ACID THERAPEUTICS, 2012, 22 (06) : A2 - A2
  • [8] Development of new RNAi therapeutics
    Liu, G.
    Wong-Staal, F.
    Li, Q. -X.
    HISTOLOGY AND HISTOPATHOLOGY, 2007, 22 (02) : 211 - 217
  • [9] RNAi therapeutics for CNS disorders
    Boudreau, Ryan L.
    Davidson, Beverly L.
    BRAIN RESEARCH, 2010, 1338 : 112 - 121
  • [10] RNAi therapeutics: An update on delivery
    Nguyen, Thu
    Menocal, Ellen M.
    Harborth, Jens
    Fruehauf, Johannes H.
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2008, 10 (02) : 158 - 167